Display options
Cite
Saiki O, Uda H. Ratio of serum amyloid A to C-reactive protein is constant in the same patients but differs greatly between patients with inflammatory diseases. Scand J Immunol. 2021;95(2):e13121doi: 10.1111/sji.13121.
Saiki, O., & Uda, H. (2022). Ratio of serum amyloid A to C-reactive protein is constant in the same patients but differs greatly between patients with inflammatory diseases. Scandinavian journal of immunology, 95(2), e13121. https://doi.org/10.1111/sji.13121
Saiki, Osamu, and Uda, Hiroshi. "Ratio of serum amyloid A to C-reactive protein is constant in the same patients but differs greatly between patients with inflammatory diseases." Scandinavian journal of immunology vol. 95,2 (2022): e13121. doi: https://doi.org/10.1111/sji.13121
Saiki O, Uda H. Ratio of serum amyloid A to C-reactive protein is constant in the same patients but differs greatly between patients with inflammatory diseases. Scand J Immunol. 2022 Feb;95(2):e13121. doi: 10.1111/sji.13121. Epub 2021 Nov 24. PMID: 34796986.
Copy Download .nbib Format: NLM
Share it on

Scand J Immunol. 2022 Feb;95(2):e13121. doi: 10.1111/sji.13121. Epub 2021 Nov 24.

Ratio of serum amyloid A to C-reactive protein is constant in the same patients but differs greatly between patients with inflammatory diseases.

Scandinavian journal of immunology

Osamu Saiki, Hiroshi Uda

Affiliations

  1. Department of Rheumatology, Higashiosaka City Medical Center, Higashiosaka City, Japan.

PMID: 34796986 DOI: 10.1111/sji.13121

Abstract

C-reactive protein (CRP) is commonly monitored to track the activity of inflammation and has become the gold standard in the management of all inflammatory diseases. Indeed, serum amyloid A (SAA) have seemed to correlate moderately with CRP, but the discrepancy of CRP and SAA levels has often been reported, especially in rheumatoid arthritis. Then, we examined CRP reflects a real magnitude of inflammation in patients with rheumatic and infectious inflammatory diseases. A total of 414 patients with infectious and non-infectious inflammatory diseases were enrolled. At initial visit, each patient underwent a clinical assessment and had also laboratory tests such as SAA and CRP. In each patient, we carried out a longitudinal analysis of CRP and SAA levels. We determined the inter-individual correlation between SAA and CRP and also clarified intra-individual changes of SAA/CRP ratio. SAA and CRP levels changed approximately linearly over time within individuals irrespective of rheumatic and infectious inflammatory diseases. However, SAA/CRP ratios differed dramatically between patients (from 0.117 to 50.8, median 5.71). In patients with high SAA/CRP ratio (>8.44), SAA is a better predictor of inflammation than CRP. In contrast, CRP is a better predictor in patients with low ratio (<3.52). Our results suggest that the SAA/CRP ratio differed greatly between individuals but was constant in intra-individuals. Low CRP levels could be accompanied by SAA levels predicting any degree of inflammation, implying that CRP is not reflecting a real magnitude of inflammation. To evaluate the real magnitude of inflammation, to access the SAA/CRP ratio in advance is essential.

© 2021 The Scandinavian Foundation for Immunology.

Keywords: C-reactive protein; SAA/CRP ratio; inflammation; serum amyloid-A

References

  1. Takahama M, Akira S, Saitoh T. Autophagy limits activation of the inflammasomes. Immunol Rev. 2018;281:62-73. - PubMed
  2. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-454. - PubMed
  3. Keyel PA. How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1. Cytokine. 2014;69:136-145. - PubMed
  4. Liu S, Ren J, Xia Q, et al. Preliminary case-control study to evaluate diagnostic values of C-reactive protein and erythrocyte sedimentation rate in differentiating active Crohn's disease from intestinal lymphoma, intestinal tuberculosis and Behcet's syndrome. Am J Med Sci. 2013;346:467-472. - PubMed
  5. Kotulska A, Kopeć-Mędrek M, Grosicka A, Kubicka M, Kucharz EJ. Correlation between erythrocyte sedimentation rate and C-reactive protein level in patients with rheumatic diseases. Reumatologia. 2015;53:243-246. - PubMed
  6. Siemons L, Ten Klooster PM, Vonkeman HE, et al. How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis. BMC Musculoskelet Disord. 2014;15(1):368. - PubMed
  7. Osei-Bimpong A, Meek JH, Lewis SM. ESR or CRP? A comparison of their clinical utility. Hematology. 2007;12:353-357. - PubMed
  8. Sorić Hosman I, Kos I, Lamot L. Serum amyloid a in inflammatory rheumatic diseases: a compendious review of a renowned biomarker. Front in Immunol. 2021;11:631299. - PubMed
  9. Cunnane G, Grehan S, Geoghegan S, et al. Serum amyloid A in the assessment of early inflammatory arthritis. J Rheumatol. 2000;27:58-63. - PubMed
  10. Connolly M, Mullan RH, McCormick J, et al. Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy. Arthritis Rheum. 2012;64:1035-1045. - PubMed
  11. Hwang YG, Balasubramani GK, Metes ID, Levesque MC, Bridges SL Jr, Moreland LW. Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker. Arthritis Res Ther. 2016;18(1):108. - PubMed
  12. Visvanathan S, Wagner C, Rojas J, et al. E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy. J Rheumatol. 2009;36:1371-1379. - PubMed
  13. Shen C, Sun XG, Liu N, et al. Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis. Mol Med Rep. 2015;11:1528-1534. - PubMed
  14. Johnson BD, Kip KE, Marroquin OC, et al. National Heart, Lung, and Blood Institute. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National heart, lung, and blood institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109:726-732. - PubMed
  15. Ladwig K-H, Marten-Mittag B, Löwel H, Döring A, Koenig W, MONICA-KORA Augsburg Cohort Study 1984-1998. C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984-1998. Eur Heart J. 2005;26(23):2537-2542. - PubMed
  16. Mayer JM, Raraty M, Slavin J, et al. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg. 2005;89:163-171. - PubMed
  17. Ahout IML, Brand KH, Zomer A, et al. Prospective observational study in two Dutch hospitals to assess the performance of inflammatory plasma markers to determine disease severity of viral respiratory tract infections in children. BMJ Open. 2017;7(6):e014596. - PubMed
  18. Kosuge M, Ebina T, Ishikawa T, et al. Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes. Circ J. 2007;71:186-190. - PubMed
  19. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805-1812. - PubMed
  20. Ally MM, Hodkinson B, Meyer PW, Musenge E, Tikly M, Anderson R. Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis. Mediators Inflamm. 2013;2013:183653. - PubMed
  21. Christensen MB, Langhorn R, Goddard A, et al. Comparison of serum amyloid A and C-reactive protein as diagnostic markers of systemic inflammation in dogs. Can Vet J. 2014;55:161-168. - PubMed
  22. Sack GH Jr. Serum Amyloid A (SAA) proteins. Subcell Biochem. 2020;94:421-436. - PubMed
  23. De Buck M, Gouwy M, Wang JM, et al. The cytokine-serum amyloid A-chemokine network. Cytokine Growth Factor Rev. 2016;30:55-69. - PubMed
  24. Hagihara K, Nishikawa T, Isobe T, Song J, Sugamata Y, Yoshizaki K. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem Biophys Res Commun. 2004;314(2):363-369. - PubMed
  25. Slaats J, Ten Oever J, van de Veerdonk FL, Netea MG. IL-1β/IL-6/CRP and IL-18/ferritin: distinct inflammatory programs in infections. PLOS Pathog. 2016;12(12):e1005973. - PubMed
  26. Yamada T, Wada A, Itoh Y, Itoh K. Serum amyloid A1 alleles and plasma concentrations of serum amyloid A. Amyloid. 1999;6:199-204. - PubMed

Publication Types

Grant support